SkinJect

Pittsburgh, United States Founded: 2015 • Age: 11 yrs
Dissolvable microneedle patches for non-melanoma skin cancer treatment are developed.
Request Access

About SkinJect

SkinJect is a company based in Pittsburgh (United States) founded in 2015. It operates as a HealthTech. SkinJect has raised $3.4 million across 4 funding rounds from investors including Velocity Fund Partners. SkinJect offers products and services including SkinJect Patch. SkinJect operates in a competitive market with competitors including Enable Injections, Aura Biosciences, Philogen, Micron Biomedical and OnQuality, among others.

  • Headquarter Pittsburgh, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.4 M (USD)

    in 4 rounds

  • Latest Funding Round
    $895.09 K (USD), Series A

    Jul 15, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of SkinJect

SkinJect offers a comprehensive portfolio of products and services, including SkinJect Patch. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

A microneedle patch developed for skin cancer treatment.

People of SkinJect
Headcount 10-50
Employee Profiles 3
Employee Profiles
People
Michael J. Fare
President & COO
People
Joseph Donnelly
CFO
People
O. Burak Ozdoganlar
Chief Technical Advisor

Unlock access to complete

Funding Insights of SkinJect

SkinJect has successfully raised a total of $3.4M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $895.09 thousand completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series A — $895,091
  • First Round

    (18 Dec 2015)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Series A - SkinJect Valuation

investors

May, 2019 Amount Series A - SkinJect Valuation

investors

May, 2016 Amount Seed - SkinJect Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in SkinJect

SkinJect has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Velocity Fund Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity investments are directed toward USA-based companies.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by SkinJect

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - SkinJect

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Skinject Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of SkinJect

SkinJect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enable Injections, Aura Biosciences, Philogen, Micron Biomedical and OnQuality, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of a wearable drug delivery solution
domain founded_year HQ Location
Therapies are developed to target and destroy cancer cells selectively.
domain founded_year HQ Location
Antibody-based drugs are developed for angiogenesis-related cancers and disorders.
domain founded_year HQ Location
Microneedle patches are developed for vaccine and drug delivery.
domain founded_year HQ Location
Therapeutics for skin cancers and related reactions are developed.
domain founded_year HQ Location
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Skinject

Frequently Asked Questions about SkinJect

When was SkinJect founded?

SkinJect was founded in 2015.

Where is SkinJect located?

SkinJect is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.

Who is the current CEO of SkinJect?

James M Nolan is the current CEO of SkinJect.

Is SkinJect a funded company?

SkinJect is a funded company, having raised a total of $3.4M across 4 funding rounds to date.

What does SkinJect do?

SkinJect is engaged in the development of innovative solutions for treating basal cell and squamous cell skin cancer. A dissolvable microneedle patch is being created as a less invasive and less painful treatment option. The company operates in the dermatology sector, addressing an unmet clinical need with a focus on reducing recurrence rates. Efforts are directed toward advancing technologies and securing regulatory clearances for commercialization in a competitive market.

Who are the top competitors of SkinJect?

SkinJect's top competitors include Philogen, Enable Injections and Aura Biosciences.

What products or services does SkinJect offer?

SkinJect offers SkinJect Patch.

Who are SkinJect's investors?

SkinJect has 1 investor. Key investors include Velocity Fund Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available